{"disease":{"id":"recurrence-cholangiocarcinoma","name":"recurrence cholangiocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04072250","title":"Surgery for Recurrent Intrahepatic Cholangiocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT04856761","title":"A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection","phase":"","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Fudan University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}